Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa

Clinical trial NCT00383903 · COMPLETED

Trial details

NCT number: NCT00383903
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Rotavirus

Start date: 2003-09-01
Primary completion: 2004-09-01
Enrollment: 472

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.